We serve 6,7-Dimethoxy-3,4-dihydroquinazoline-4-one CAS:13794-72-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:6,7-Dimethoxy-3,4-dihydroquinazoline-4-one
CAS.NO:13794-72-4
Synonyms:
6,7-Dimethoxy-4-quinazolinol
6,7-Dimethoxy-3H-quinazolin-4-one
6,7-Dimethoxy-4-hydroxyquinazoline
6,7-dimethoxy-1H-quinazolin-4-one
6,7-Dimethoxy-3,4-dihydroquinazolin-4-one
6,7-Dimethoxyquinazolin-4(3H)-one
6,7-Dimethoxy-4(3H)-quinazolinone
Molecular Formula:C10H10N2O3
Molecular Weight:206.19800
Physical and Chemical Properties:
Density: 1.33 g / cm3
Boiling point: 374.1ºC at 760 mmHg
Melting point: 309-311ºC
Flash point: 221.0±25.9 °C
Refractive index: 1.601
Specification:
Appearance:white crystalline powder
Purity:≥98%
Moisture Content: ≤1%
Packing:
25kg cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Gefitinib CAS:184475-35-2
Contact us for information like 6,7-Dimethoxy-3,4-dihydroquinazoline-4-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,6,7-Dimethoxy-4(3H)-quinazolinone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,6,7-Dimethoxy-3,4-dihydroquinazolin-4-one Use and application,6,7-Dimethoxy-3,4-dihydroquinazoline-4-one technical grade,usp/ep/jp grade.
Related News: Here’s what Apple told CNN Business in a statement:4-Nitro-1,3-phenylenediamine manufacturer Commonly used generic drugs: the products whose patents have expired and the generic drugs of many companies have participated in the competition, and the market demand is large.Benzoyl chloride supplier With the continuous accumulation of the API industry and the increasing maturity of the market, competition in China’s API industry will become increasingly fierce.Ethyl 2-(3-cyano-4-hydroxyphenyl)-4-methylthiazole-5-carboxylate vendor The move could force international drugmakers to further cut prices and enable copycat medicines to replace imported off-patent brands at faster pace.Madeleine Roche, Associate Pharmaceutical Analyst at GlobalData, comments: “Within the top 20 global companies that spent the most on R&D in 2018, the top spender – despite having the second smallest annual revenue of the group at $15.28 billion – is Celgene, whose R&D spend was equal to 37% of its annual revenue.
